These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20545695)

  • 1. Osteopontin is a new target molecule for ovarian clear cell carcinoma therapy.
    Matsuura M; Suzuki T; Saito T
    Cancer Sci; 2010 Aug; 101(8):1828-33. PubMed ID: 20545695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression.
    Kato N; Motoyama T
    Histopathology; 2008 May; 52(6):682-8. PubMed ID: 18393978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
    Desai B; Rogers MJ; Chellaiah MA
    Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma.
    Matsuura M; Suzuki T; Suzuki M; Tanaka R; Ito E; Saito T
    Oncol Rep; 2011 Jan; 25(1):41-7. PubMed ID: 21109955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells.
    Wu XL; Lin KJ; Bai AP; Wang WX; Meng XK; Su XL; Hou MX; Dong PD; Zhang JJ; Wang ZY; Shi L
    World J Gastroenterol; 2014 Aug; 20(30):10440-8. PubMed ID: 25132760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin stimulates invasion of NCI-h295 cells but is not associated with survival in adrenocortical carcinoma.
    Weismann D; Briese J; Niemann J; Grüneberger M; Adam P; Hahner S; Johanssen S; Liu W; Ezzat S; Saeger W; Bamberger AM; Fassnacht M; Schulte HM; Asa SL; Allolio B; Bamberger CM
    J Pathol; 2009 Jun; 218(2):232-40. PubMed ID: 19326399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
    Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.
    Cheng J; Huo DH; Kuang DM; Yang J; Zheng L; Zhuang SM
    Cancer Res; 2007 Jun; 67(11):5141-7. PubMed ID: 17545592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines.
    Bhattacharya SD; Garrison J; Guo H; Mi Z; Markovic J; Kim VM; Kuo PC
    Surgery; 2010 Aug; 148(2):291-7. PubMed ID: 20576283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis.
    Sun BS; You J; Li Y; Zhang ZF; Wang CL
    Chin Med J (Engl); 2013; 126(9):1683-8. PubMed ID: 23652051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
    Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
    Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells.
    Lin F; Li Y; Cao J; Fan S; Wen J; Zhu G; Du H; Liang Y
    Mol Biol Rep; 2011 Nov; 38(8):5205-10. PubMed ID: 21188534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
    Gong M; Lu Z; Fang G; Bi J; Xue X
    Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
    Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of integrin alpha3 expression associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells.
    Suzuki N; Higashiguchi A; Hasegawa Y; Matsumoto H; Oie S; Orikawa K; Ezawa S; Susumu N; Miyashita K; Aoki D
    Hum Cell; 2005 Sep; 18(3):147-55. PubMed ID: 17022147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POU6F1 is the transcription factor that might be involved in cell proliferation of clear cell adenocarcinoma of the ovary.
    Yoshioka N; Suzuki N; Uekawa A; Kiguchi K; Ishizuka B
    Hum Cell; 2009 Nov; 22(4):94-100. PubMed ID: 19874398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma.
    Takafuji V; Forgues M; Unsworth E; Goldsmith P; Wang XW
    Oncogene; 2007 Sep; 26(44):6361-71. PubMed ID: 17452979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.
    Kiss T; Jámbor K; Koroknai V; Szász I; Bárdos H; Mokánszki A; Ádány R; Balázs M
    Pathol Oncol Res; 2021; 27():581395. PubMed ID: 34257527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
    Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
    Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin.
    Kale S; Raja R; Thorat D; Soundararajan G; Patil TV; Kundu GC
    Oncogene; 2014 May; 33(18):2295-306. PubMed ID: 23728342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.